跳至主要内容
临床试验/NCT00523120
NCT00523120终止2 期

Topical Voltaren as an Alternative Treatment for Otitis Externa

Sieff Medical Center1 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2008年9月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
状态
终止
发起方
入组人数
20
试验地点
1
主要终点
reducing oral analagestic use

研究概览

简要总结

Voltaren being a Non-steroidal anti-inflammatory drug (NSAID) drug may be used as a single drug therapy in otitis externa being both therapeutic and analgesic thus reducing consumption of oral analgesia.

详细描述

anticipated advantages are: reduction of inflammation and edema, no fungal overpopulation- when steroids are employed, contains boric acid as an ingredient, high safety profile, can be switched to antibiotic therapy later, can be used in conjunction wit steroids

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Care Provider)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Adults having otitis externa as single diagnosis mild to moderate

排除标准

  • Pregnant women
  • Immune compromise
  • Starting other treatment
  • Moderate to severe otitis externa

研究组 & 干预措施

1

Active Comparator

voltaren ophta

干预措施: diclofenac sodium (Drug)

2

Active Comparator

dexotic

干预措施: dexotc (Drug)

结局指标

主要结局

reducing oral analagestic use

时间窗: 1 week

次要结局

  • adding an alternative treatment for otitis externa(1 week)

研究者

发起方
Sieff Medical Center
申办方类型
Other
责任方
Principal Investigator
主要研究者

victor kizhner

Victor Kizhner MD

Sieff Medical Center

研究点 (1)

Loading locations...

相似试验